Skip to main content
Premium Trial:

Request an Annual Quote

NantHealth, Blue Shield Partner on Personalized Medicine Venture

NEW YORK (GenomeWeb News) – Digital medicine company NantHealth, a subsidiary of NantWorks, will partner with Blue Shield of California and work with other collaborators to create a personalized medicine center that will integrate genomic data into a patient monitoring and evidence-based care system, NantHealth said today.

Under the collaboration, NantHealth and Blue Shield will work with Saint John's Health Center in Santa Monica, Calif., to establish a clinically-based continuous learning center (CLC) as part of a new accountable care organization that Blue Shield will create with Access Medical Group and Saint John's.

The CLC will provide a "comprehensive view" of a patient's medical information, including real-time wireless monitoring for chronic conditions, NantHealth said. To create this system, the center will integrate genomic data systems, supercomputing, and secure networks to provide molecular-based medicine to Saint John's doctors.

"This is a transformative first step towards a new model, and that model being proactively sustaining health rather than reactively treating acute and chronic illnesses," NantWorks and NantHealth Founding Chairman and CEO Patrick Soon-Shiong said in a statement. "By providing the right care to the right patient at the right time we will transform healthcare by enabling people to live healthy more vibrant lives, translating into better outcomes and lower costs in the United States."

NantHealth, also based in Santa Monica, seeks to bring together a range of digital technologies to advance healthcare and research through an evidence-based, genomically-informed approach to care through the use of new diagnostics and therapeutics.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.